PTC Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
21.05.24
/
50%
€35.00
Target price
21.05.25
€48.82
Performance (%)
-12.57%
Price
25.07.24
€30.60
Summary
This prediction is currently active. The prediction for PTC Therapeutics Inc. disappoints with a performance of -12.57%. This prediction currently runs until 21.05.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
PTC Therapeutics Inc. | 1.987% | 1.987% |
iShares Core DAX® | 0.039% | 0.567% |
iShares Nasdaq 100 | -4.018% | -5.554% |
iShares Nikkei 225® | -2.389% | -1.434% |
iShares S&P 500 | -2.115% | -2.351% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at JPMorgan Chase & Co. from $43.00 to $53.00. They now have an "overweight" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€31.20
20.06.24
20.06.24
€49.47
20.06.25
20.06.25
-2.56%
25.07.24
25.07.24